Cite
HARVARD Citation
Jung, M. et al. (2022). Nicotinamide (niacin) supplement increases lipid metabolism and ROS‐induced energy disruption in triple‐negative breast cancer: potential for drug repositioning as an anti‐tumor agent. Molecular oncology. 16 (9), pp. 1795-1815. [Online].